Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution

Table 3

Risk groups based on HCT-CI and age along with the OS of each subgroup.

Age groups	HCT-CI	𝑁 (%)	Median OS (months)	Events
20–30	0–2	34 (85.0)	62	17
	>2	6 (15.0)	11	4
	Total	40	62	21
31–40	0–2	37 (77.1)	22	23
	>2	11 (22.9)	13	7
	Total	48	20	30
41–50	0–2	44 (59.5)	8	26
	>2	30 (40.5)	8	21
	Total	74	8	47
51–60	0–2	36 (64.3)	6	26
	>2	20 (35.7)	5	19
	Total	56	6	45
61–70	0–2	18 (66.7)	6	14
	>2	9 (33.3)	6	8
	Total	27	6	22